Moderna

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect children under the age of 6.

Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.

A 50-microgram dose of Moderna’s new vaccine doubled the antibodies against the omicron variant six months after administration.

Many Americans can now get a second COVID-19 booster, but it’s hard to tell who really needs another shot right now and who could wait.

Moderna says its COVID-19 vaccine works in babies, toddlers and preschoolers

The request comes two days after Pfizer asked the Food and Drug Administration to authorize a second booster shot for adults 65 and older.

Drugmaker Moderna has asked the Food and Drug Administration to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults

Moderna says U.S. health regulators have given full approval to its COVID-19 vaccine after reviewing additional data on its safety and effectiveness

Nearly 60 participants were given their first doses of the experimental HIV vaccine Thursday

Moderna is testing an omicron-specific COVID-19 vaccine booster.

Three new U.S. studies offer more evidence that the COVID-19 vaccines are standing up to the omicron variant, at least among people who have gotten booster shots

Moderna says its COVID-19 booster does appear to provide protection against the omicron variant.

The announcement from the drug company is the latest sign that booster shots are an effective way to protect against the new variant.

This is a big change for vaccine recommendations and concerns a very rare but potentially deadly blood clot risk linked to the Johnson & Johnson shot.

n advisory panel to the Centers for Disease Control and Prevention suggested prop get the Moderna or Pfizer COVID-19 mRNA vaccines instead of Johnson & Johnson’s whenever the former two are available.

U.S. health officials say most Americans should get the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot

The CDC is urging people 50 and older to get a COVID booster vaccine after the FDA has given their approval for the use of booster doses of both the Moderna and Pfizer COVID-19 vaccines for everyone over 18. The Centers for Disease Control and Prevention’s director signed off on boosters for all adults late Friday.

Moderna’s revised application comes as the FDA is expected to authorize Pfizer and BioNTech’s booster shots for all adults as early as this week.

U.S. regulators are studying an exceedingly rare risk of heart inflammation — though public health officials have stressed that COVID-19 itself can cause heart inflammation at higher rates than the cases caused by the vaccine.

NBC Connecticut’s Dan Corcoran breaks down the newest booster shot updates and who is eligible for the different options.